I-Mab (IMAB) Stock Chart & Stock Price History $5.09 +0.38 (+8.07%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$5.12 +0.04 (+0.69%) As of 08/22/2025 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock I-Mab Stock Price Performance The I-Mab (IMAB) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 318.93%, with a year-to-date return of 498.82%. In the past month, the stock has increased 140.09%, reflecting recent market activity. As of the latest close, I-Mab traded at $5.09 with a market cap of $415.65 million and volume of 3.48 million shares. Five years ago, the stock traded at $30.30, representing a 83.20% decrease over that period. At the time, it had a market cap of $1.68 billion and a volume of 66,491 shares. Receive IMAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for I-Mab and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+20.90%1 Month Performance+140.09%3 Month Performance+414.14%Year-To-Date Performance+498.82%1 Year Performance+318.93%5 Year Performance-83.20% IMAB Stock Chart for Sunday, August, 24, 2025 IMAB Chart by TradingView I-Mab Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/22/2025$4.71$5.09+8.07%$5.64$4.743.48 million shs$415.65 million08/21/2025$4.52$4.71+4.20%$4.90$4.341.22 million shs$384.62 million08/20/2025$4.21$4.52+7.36%$4.69$4.131.50 million shs$369.10 million08/19/2025$5.09$4.21-17.29%$5.14$4.212.76 million shs$343.79 million08/18/2025$4.87$5.09+4.52%$5.28$4.731.73 million shs$415.65 million08/15/2025$5.16$4.87-5.62%$5.90$4.714.91 million shs$396.91 million08/14/2025$4.24$5.16+21.70%$5.35$4.335.57 million shs$420.54 million08/13/2025$3.85$4.24+10.13%$4.37$3.892.22 million shs$345.56 million08/12/2025$3.89$3.85-1.03%$3.86$3.62990,083 shs$313.78 million08/11/2025$3.41$3.89+14.08%$3.94$3.452.85 million shs$317.04 million Get the Latest News and Ratings for IMAB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for I-Mab and its competitors with MarketBeat's FREE daily newsletter. 08/08/2025$3.51$3.41-2.85%$3.66$3.301.13 million shs$277.92 million08/07/2025$3.74$3.51-6.15%$4.18$3.433.87 million shs$286.07 million08/06/2025$3.37$3.74+10.98%$4.10$3.374.91 million shs$304.81 million08/05/2025$2.93$3.37+15.02%$3.40$2.933.53 million shs$274.66 million08/04/2025$2.62$2.93+11.83%$3.12$2.784.90 million shs$238.80 million08/01/2025$2.01$2.62+30.35%$3.44$2.2544.48 million shs$213.53 million07/31/2025$2.03$2.01-0.99%$2.13$1.94269,081 shs$163.82 million07/30/2025$1.70$2.03+19.41%$2.18$1.751.82 million shs$165.45 million07/29/2025$1.87$1.70-9.09%$1.91$1.65581,726 shs$138.82 million07/28/2025$2.11$1.87-11.37%$2.14$1.83562,931 shs$152.41 million07/25/2025$2.12$2.11-0.47%$2.15$2.08105,961 shs$172.30 million07/24/2025$2.11$2.12+0.47%$2.13$2.0893,819 shs$173.12 million07/23/2025$2.08$2.11+1.44%$2.13$2.01271,857 shs$172.30 million Related Companies WAVE Life Sciences Stock Price Chart Janux Therapeutics Stock Price Chart Edgewise Therapeutics Stock Price Chart Ardelyx Stock Price Chart Harrow Stock Price Chart ARS Pharmaceuticals Stock Price Chart Schrodinger Stock Price Chart Amphastar Pharmaceuticals Stock Price Chart Vera Therapeutics Stock Price Chart AbCellera Biologics Stock Price Chart Receive IMAB Stock News and Ratings via EmailSign-up to receive the latest news and ratings for I-Mab and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:IMAB) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding I-Mab Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share I-Mab With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access